The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Abstract Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. Methods Between August 2004 and November 2014, 104 patients with BCLC stage B/C HCC were enrolled at the Affili...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2017-09-01
Col·lecció:	BMC Cancer
Matèries:	Hepatocellular carcinoma Sorafenib Transarterial chemoembolization Portal vein tumor thrombus Adverse events
Accés en línia:	http://link.springer.com/article/10.1186/s12885-017-3545-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!